The Fort Worth Press - Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5

USD -
AED 3.6725
AFN 66.106128
ALL 82.462283
AMD 381.646874
ANG 1.790403
AOA 916.999545
ARS 1451.493901
AUD 1.49923
AWG 1.8025
AZN 1.69889
BAM 1.666106
BBD 2.015555
BDT 122.381003
BGN 1.6667
BHD 0.376969
BIF 2960.464106
BMD 1
BND 1.286514
BOB 6.930128
BRL 5.515498
BSD 1.000707
BTN 90.075562
BWP 13.139445
BYN 2.939776
BYR 19600
BZD 2.012659
CAD 1.372555
CDF 2164.999583
CHF 0.793565
CLF 0.022945
CLP 900.13991
CNY 6.996402
CNH 6.97704
COP 3769.96
CRC 497.073782
CUC 1
CUP 26.5
CVE 93.933689
CZK 20.586899
DJF 177.719966
DKK 6.36617
DOP 63.090461
DZD 129.565162
EGP 47.7078
ERN 15
ETB 155.306806
EUR 0.85232
FJD 2.273302
FKP 0.741981
GBP 0.74363
GEL 2.694963
GGP 0.741981
GHS 10.508067
GIP 0.741981
GMD 74.000247
GNF 8754.802491
GTQ 7.675532
GYD 209.36909
HKD 7.78393
HNL 26.382819
HRK 6.414503
HTG 130.968506
HUF 327.71999
IDR 16694
ILS 3.186885
IMP 0.741981
INR 89.986897
IQD 1310.962883
IRR 42124.999787
ISK 125.469873
JEP 0.741981
JMD 159.029535
JOD 0.70898
JPY 156.876016
KES 129.090012
KGS 87.443501
KHR 4009.813693
KMF 419.999716
KPW 900.043914
KRW 1444.639978
KWD 0.30769
KYD 0.833994
KZT 507.398605
LAK 21633.571009
LBP 89616.523195
LKR 309.880992
LRD 178.128754
LSL 16.565363
LTL 2.95274
LVL 0.60489
LYD 5.41968
MAD 9.125364
MDL 16.842652
MGA 4593.353608
MKD 52.457549
MMK 2099.836459
MNT 3559.101845
MOP 8.023887
MRU 39.738642
MUR 46.249823
MVR 15.449757
MWK 1735.285849
MXN 18.022855
MYR 4.058039
MZN 63.909696
NAD 16.565293
NGN 1445.369727
NIO 36.826906
NOK 10.08779
NPR 144.120729
NZD 1.738325
OMR 0.384498
PAB 1.000716
PEN 3.366031
PGK 4.262823
PHP 58.878498
PKR 280.231968
PLN 3.596297
PYG 6569.722371
QAR 3.640127
RON 4.3408
RSD 99.96038
RUB 79.099677
RWF 1458.083093
SAR 3.750501
SBD 8.136831
SCR 13.817013
SDG 601.501981
SEK 9.22704
SGD 1.28666
SHP 0.750259
SLE 24.050069
SLL 20969.503664
SOS 570.932045
SRD 38.1265
STD 20697.981008
STN 20.871136
SVC 8.756506
SYP 11059.149576
SZL 16.560607
THB 31.488021
TJS 9.241824
TMT 3.51
TND 2.91815
TOP 2.40776
TRY 42.955704
TTD 6.802286
TWD 31.384502
TZS 2470.315981
UAH 42.338589
UGX 3623.089636
UYU 39.186789
UZS 12013.255301
VES 297.770445
VND 26300
VUV 120.744286
WST 2.776281
XAF 558.798674
XAG 0.013939
XAU 0.000231
XCD 2.70255
XCG 1.803607
XDR 0.694966
XOF 558.798674
XPF 101.595577
YER 238.450454
ZAR 16.57019
ZMK 9001.197453
ZMW 22.191554
ZWL 321.999592
  • SCS

    0.0200

    16.14

    +0.12%

  • JRI

    0.0300

    13.61

    +0.22%

  • NGG

    -0.4200

    77.35

    -0.54%

  • BCE

    0.2500

    23.82

    +1.05%

  • CMSD

    0.0200

    23.15

    +0.09%

  • RIO

    -0.4900

    80.03

    -0.61%

  • BCC

    -0.1900

    73.6

    -0.26%

  • RBGPF

    0.3400

    81.05

    +0.42%

  • CMSC

    -0.0334

    22.65

    -0.15%

  • GSK

    -0.2600

    49.04

    -0.53%

  • BTI

    0.0700

    56.62

    +0.12%

  • AZN

    -0.5800

    91.93

    -0.63%

  • RYCEF

    0.0500

    15.5

    +0.32%

  • BP

    -0.0200

    34.73

    -0.06%

  • RELX

    -0.6900

    40.42

    -1.71%

  • VOD

    -0.0200

    13.21

    -0.15%

Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5
Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5

Join NDT Pharmaceuticals' Exclusive Live Investor Webinar and Q&A Session on November 5

ORLANDO, FLORIDA / ACCESS Newswire / October 30, 2025 / RedChip Companies will host an investor webinar with NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative consumer health and wellness solutions, on November 5, 2025, at 4:15 p.m. ET.

Text size:

The exclusive event will feature NDT Pharmaceuticals' President and CEO, Zach O'Shea, who will share insights into how NDT Pharmaceuticals is redefining biosafety and infection control through its wholly owned subsidiary, Good Salt Life. The company's vertically integrated platform combines proprietary chemical delivery technology, EPA-approved antimicrobial solutions, and data-driven disinfection protocols to create sustainable, science-backed ecosystems that protect people, pets, and the planet. O'Shea will highlight the company's strategic partnership with a leading animal health company, which expands Good Salt Life's global footprint across livestock, aquaculture, and companion animal markets, as well as deployments with marquee clients including United Airlines, Carnival Cruise Line, Marriott, and the NFL. With a $148 billion total addressable market and projected revenue growth from $2.4 million in 2025 to $500 million by 2030, NDT Pharmaceuticals is positioned as a high-growth, category-defining player in the health, safety, and wellness industry.

A live question and answer session will follow the presentation.

To register for the free webinar, please visit: https://www.redchip.com/webinar/NDTP/82713029276

Questions can be pre-submitted to [email protected] or online during the live event.

About NDT Pharmaceuticals, Inc. (OTC PINK:NDTP)

NDT Pharmaceuticals, Inc. is a publicly traded company focused on advancing innovative consumer health and wellness solutions. Through its subsidiary, Good Salt Life, the Company has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in sustainable, science-driven brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.

About Good Salt™ Life, Inc.

Good Salt Life is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.

About RedChip Companies

RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.

To learn more about RedChip's products and services, please visit: https://www.redchip.com/corporate/investor_relations

"Discovering Tomorrow's Blue Chips Today"™

Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/

Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies

Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/

Follow RedChip on Twitter: https://twitter.com/RedChip

Follow RedChip on YouTube: https://www.youtube.com/@redchip

Follow RedChip on Rumble: https://rumble.com/c/c-3068340

Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest

Contact:

Dave Gentry
RedChip Companies, Inc.

1-800-REDCHIP (733-2447)
1-407-644-4256
[email protected]

SOURCE: RedChip Companies, Inc.



View the original press release on ACCESS Newswire

M.McCoy--TFWP